Klaus M. Leisinger | Academic Influence

Klaus M. Leisinger's AcademicInfluence.com Rankings

Klaus M. Leisinger

Economics

#2302

World Rank

#2632

Historical Rank

economics Degrees

Download Badge

Economics

Klaus M. Leisinger's Degrees

PhD Economics University of Basel

Why Is Klaus M. Leisinger Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Klaus M. Leisinger is a social scientist and economist. He is founder and president of the Global Values Alliance in Basel. Until 2012 he was managing director and chairman of the Board of Trustees of the Novartis Foundation in Basel, Switzerland.

(See a Problem?)

Klaus M. Leisinger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation. (2005) (113)
Corporate Philanthropy: The “Top of the Pyramid” (2007) (74)
Corporate Responsibilities for Access to Medicines (2009) (43)
Capitalism with a Human Face The UN Global Compact (2007) (42)
Six Billion and Counting: Population Growth and Food Security in the 21st Century (2002) (39)
Survival in the Sahel: an ecological and developmental challenge. (1995) (35)
Improving Access to Medicines in Low and Middle Income Countries: Corporate Responsibilities in Context (2012) (31)
BIOTECHNOLOGY AND FOOD SECURITY (1999) (30)
Ethical challenges of agricultural biotechnology for developing countries. (2000) (23)
Sociopolitical effects of new biotechnologies in developing countries (1996) (21)
Capitalism with a Human Face (2007) (20)
Biotechnology of Food Crops in Developing Countries (1999) (19)
Opportunities and Risks of the United Nations Global Compact (2003) (19)
Business needs to embrace sustainability targets (2015) (17)
Humanism in Business: On corporate responsibility for human rights (2009) (16)
Sustainable development at the turn of the century: perceptions and outlook (1998) (14)
Developing the business-society nexus through corporate responsibility expectations in India (2019) (13)
Six Billion and Counting (2002) (13)
An Analysis of the Conceptual Landscape of Corporate Responsibility in Academia (2015) (11)
Poverty, Disease, and Medicines in Low- and Middle-Income Countries: The Roles and Responsibilities of Pharmaceutical Corporations (2012) (10)
The influence of context and culture on corporate responsibility expectations in South Africa (2014) (7)
Disentangling risk issues: biotechnology for developing-country agriculture problems and opportunities (1999) (7)
Corporate Leadership in Times of Public Distrust (2016) (6)
Food Security for a Growing World Population – 200 Years After Malthus, Still an Unsolved Problem (1996) (6)
Multinational Corporations, Governance Deficits, and Corruption: Discussing a Complex Issue from the Perspective of Business Ethics (1998) (6)
Corporate Responsibility in a World of Cultural Diversity and Pluralism of Values (2015) (6)
Access to Healthcare and the Pharmaceutical Sector (2011) (6)
The Contribution of Genetic Engineering to the Fight against Hunger in Developing Countries (1999) (6)
The Role of Corporations in Shaping Globalization with a Human Face (2009) (4)
Sustainable Development: A Common Challenge for North and South (1995) (4)
The 'Political Economy' of Agricultural Biotechnology for the Developing World (2000) (4)
Overcoming poverty and respecting human rights: ten points for serious consideration (2004) (3)
Yes: Stop Blocking Progress (2000) (3)
Population growth, food security, and civil society: the hunger problem can be solved. (2000) (3)
How well do Chinese corporate responsibility expectations map onto an international corporate responsibility scale? (2015) (3)
Stretching the Limits of Corporate Responsibility (2008) (3)
Corporate Responsibility for Pharmaceutical Corporations (2009) (3)
Working Together to Make the World a Healthier Place: Desiderata for the Pharmaceutical Industry (2019) (3)
Making sense of the United Nations Global Compact human rights principles (2010) (3)
Healthy Volunteers in Clinical Studies (2018) (3)
Bad Medicine. The Prescription Drug Industry in the Third World . M. Silverman, M. Lydecker, Ph. R. Lee. Stanford, California: Stanford University Press, 1992, ISBN 0-8047-1669-2. (1993) (2)
Setting the priorities for action. (2002) (2)
Corporate Responsibility Expectations in China: Advanced Business and Economics Students from Beijing (2017) (2)
Using the World Ethos Body of Thought as a Compass for Managers some Thoughts on the Practical Application of a Philosophical Concept (2018) (2)
All Our People: Population Policy With A Human Face (1994) (2)
Opportunities and Risks of the United Nations Global Compact The Novartis Case Study (2003) (2)
Biotechnology in third world agriculture: some socio-economic considerations. (1999) (1)
Intellectual Property and Access to Essential Medicines: A Tenuous Link? (2013) (1)
Corporate Sustainability, Global Values and Pluralistic Societies: What Can We Know? What Ought We to Do? What May We Hope? (2017) (1)
Corporate Philanthropy as an Integrated Concept: The Case of the Novartis Foundation for Sustainable Development (2010) (1)
The Global Economic Manifesto: A Retrospective (2015) (1)
"The Global Economic Manifesto: A Retrospective": A Response from Two Co-Authors (2015) (1)
Mali: a typical Sahelian country. (1995) (0)
Agricultural biotechnology and the poor : proceedings of an international conference, Washington, D.C., 21-22 October 1999. Ethical challenges of agricultural biotechnology in developing countries. (2000) (0)
Global Responsibility for Sustainable Development: The Role of Multinational Corporations (1998) (0)
Bioethics Here and in Poor Countries: A Comment (1993) (0)
Sustainable food security: role of the private sector. (2003) (0)
The machinery of policy making in LDCs (1973) (0)
Corporate responsibilities in the context of the post-2015 sustainable development agenda (2014) (0)
How well do Chinese corporate responsibility expectations map onto an international corporate responsibility scale? (2015) (0)
The Art oft Leading. The Significance of Personality and Character in the Choice of Business Leaders (2018) (0)
5 Corporate Responsibility for Pharmaceutical Corporations (2011) (0)
ACSEP Session #2: Innovative Philanthropy in Health, 2:45pm to 3:45pm (2013) (0)
Using the World Ethos Body of Thought as a Compass for Managers some Thoughts on the Practical Application of a Philosophical Concept (2018) (0)
Corporate Responsibilities for Access (2016) (0)
Business Ethics, Multinational Corporations and Developing Countries (1999) (0)
Issues in Development: a Guide (1983) (0)
Are “Human Rights” the “Business of Business”? (2020) (0)
Moral Common Sense (1991) (0)

This paper list is powered by the following services:

Other Resources About Klaus M. Leisinger

en.wikipedia.org

What Schools Are Affiliated With Klaus M. Leisinger?

Klaus M. Leisinger is affiliated with the following schools:

University of Basel

Image Attributions

Image Source for Klaus M. Leisinger